BenefitsPRO: Employee Benefits News, Trends & Sales Tips

Profits over patients? States scrutinize nonprofit hospitals' charity spending

By Andy Miller and Markian Hawryluk

A recent Pennsylvania ruling striking down Tower Health's tax-exempt status sent a warning shot to the roughly 3,000 nongovernment tax-exempt hospitals nationwide, as states consider legislation to better define charity care.

Read Story

Update

Senator Sanders will block NIH nominee until Biden offers plan to lower drug prices

Update

Opioid settlement payouts: How is the $50 billion to localities being distributed?

Recommended Just For You

Update Stories

July 10, 2023

Biden's newest student debt relief plan will likely face legal challenges too

President Biden's new SAVE plan is an income-driven repayment plan that will cut borrower's monthly payments in half, but it could still face legal attacks as it relies on the Higher Education Act, which governs financial assistance.

Read

July 06, 2023

Amid industry lawsuits, CMS issues new guidance on drug price negotiation program

Following lawsuits filed by Merck, Bristol Myers Squibb, PhRMA and the US Chamber of Commerce challenging the drug price negotiation plan, the CMS revised its guidance, allowing drug companies to publicly discuss the talks.

Read

July 03, 2023

DEA extends telemedicine option for prescribing controlled medications

Telehealth rules, which were created during the pandemic, allowed for the prescribing of controlled substances without an in-person visit, will stay in place until November 11.

Read

June 30, 2023

The Pregnant Workers Fairness Act: Now in effect, but does it offer enough protection?

The law, which took effect June 27, requires employers to provide "reasonable accommodations" to pregnant workers, but public health experts say not nearly enough is known about which work circumstances are dangerous.

Read

June 30, 2023

Will the doctor see you now? The changing primary care landscape

Hospitals, insurers like Aetna-CVS Health and corporate giants like Amazon are on a buying spree, snapping up primary care practices, furthering a move away from the neighborhood doctor.

Read

June 27, 2023

The race is on: Some drugmakers falling behind in developing new weight loss pills

Drugmakers have been rushing to develop obesity pills (to rival obesity shots like Wegovy), angling for a piece of a market that some estimate will one day be worth as much as $100 billion.

Read

June 26, 2023

Cancer patients can't get meds as U.S. drugmakers abandon cheap generics

The main cause, experts agree, is the underlying weakness of the generic drug industry, which are made mostly overseas because U.S. manufacturers are setting their sights instead on high-priced drugs with plump profit margins.

Read

‹ ‹ PREV 9 10 11 ... 16 › NEXT ›

Update

Top Update Stories

Profits over patients? States scrutinize nonprofit hospitals' charity spending

Senator Sanders will block NIH nominee until Biden offers plan to lower drug prices

Opioid settlement payouts: How is the $50 billion to localities being distributed?

Recommended Just For You

Update Stories

Biden's newest student debt relief plan will likely face legal challenges too

Amid industry lawsuits, CMS issues new guidance on drug price negotiation program

DEA extends telemedicine option for prescribing controlled medications

The Pregnant Workers Fairness Act: Now in effect, but does it offer enough protection?

Will the doctor see you now? The changing primary care landscape

The race is on: Some drugmakers falling behind in developing new weight loss pills

Cancer patients can't get meds as U.S. drugmakers abandon cheap generics